HNGE - Hinge Health, Inc.
The average of price targets set by Wall Street analysts indicates a potential upside of 25.1% in Hinge Health Inc. (HNGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Hinge Health Inc. (HNGE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Hinge Health NYSE: HNGE reported first-quarter 2026 results that topped its prior outlook and raised its full-year guidance, citing stronger-than-expected member engagement, growth in eligible lives and continued operating leverage from artificial intelligence and automation.
Hinge Health beats Q1 estimates as revenues jump 47% and margins expand, while strong guidance and client growth drive a sharp after-hours stock jump.
Hinge Health, Inc. (HNGE) Q1 2026 Earnings Call Transcript
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026. “We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs,” said Daniel Perez, Co-Founder and CEO, Hinge Health. “Based on this momentum, we're raising our full-year revenue outlook by approximat.
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today introduced its Migraine Care Program, offering rapid drug-free pain relief, personalized trigger management, and expert-led prevention for members. With meaningful overlap between the treatments and clinical best practices for migraine and musculoskeletal (MSK) care, Hinge Health is leveraging its proven expertise in nerve stimulation, exercise therapy, and behavior change to deliver comprehensive, whole-person care for peopl.
Hinge Health (NYSE: HNGE - Get Free Report) and 10x Genomics (NASDAQ: TXG - Get Free Report) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, earnings, valuation, dividends and analyst recommendations. Profitability This table compares Hinge Health and
50,000 Class A shares were sold on April 1, 2026, with a transaction value of ~$1.92 million based on a weighted average price of $38.46 per share. This disposition represented 100.00% of Mecklenburg's direct Class A Common Stock holdings at the time, reducing his direct Class A position to zero.
Hinge Health Inc. (NYSE: HNGE - Get Free Report) Chairman Gabriel M.I. Mecklenburg sold 50,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $38.46, for a total value of $1,923,000.00. Following the sale, the chairman directly owned 50,000 shares of the company's
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close on Tuesday, May 5, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations websit.
HNGE pairs rapid growth and AI-driven efficiency with rising execution risks as 2026 slowdown, margin pressure, and engagement reliance cloud outlook.
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced its expansion throughout the public sector, now delivering musculoskeletal (MSK) care to employees across 24 state employee health plan clients. With MSK conditions continuing to be a top healthcare cost driver, leading state governments are taking a different approach, prioritizing early intervention, accessibility, and evidence-based care that meets employees where they are. “Providing our team with a digital prog.
Hinge Health Inc. (NYSE: HNGE - Get Free Report) CFO James Budge sold 11,006 shares of the firm's stock in a transaction on Monday, March 23rd. The stock was sold at an average price of $42.26, for a total value of $465,113.56. Following the completion of the transaction, the chief financial officer owned 401,427 shares of
Hinge Health Inc. (NYSE: HNGE - Get Free Report) President James Pursley sold 15,000 shares of the business's stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $42.26, for a total value of $633,900.00. Following the completion of the transaction, the president owned 732,104 shares of the company's
HeartSciences (NASDAQ: HSCS - Get Free Report) and Hinge Health (NYSE: HNGE - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership. Valuation and Earnings This table compares HeartSciences and Hinge
Hinge Health Inc. (NYSE: HNGE - Get Free Report) has been given an average recommendation of "Moderate Buy" by the nineteen brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating, sixteen have issued a buy rating and one
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief Operating Officer of Freshworks Inc., where he oversees accounting, finance, IT, security, workplace, corporate strategy and revenue enablement. “Tyler brings decades of deep operating experience,” said Daniel Perez, Co-Founder and CEO, Hinge Health. “His track record of scaling public companies wit.
Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock?
The mean of analysts' price targets for Hinge Health Inc. (HNGE) points to a 26.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.